Taurine and neural cell damage - PubMed

Review

Taurine and neural cell damage

P Saransaari et al. Amino Acids. 2000.

Abstract

The inhibitory amino acid taurine is an osmoregulator and neuromodulator, also exerting neuroprotective actions in neural tissue. We review now the involvement of taurine in neuron-damaging conditions, including hypoxia, hypoglycemia, ischemia, oxidative stress, and the presence of free radicals, metabolic poisons and an excess of ammonia. The brain concentration of taurine is increased in several models of ischemic injury in vivo. Cell-damaging conditions which perturb the oxidative metabolism needed for active transport across cell membranes generally reduce taurine uptake in vitro, immature brain tissue being more tolerant to the lack of oxygen. In ischemia nonsaturable diffusion increases considerably. Both basal and K+-stimulated release of taurine in the hippocampus in vitro is markedly enhanced under cell-damaging conditions, ischemia, free radicals and metabolic poisons being the most potent. Hypoxia, hypoglycemia, ischemia, free radicals and oxidative stress also increase the initial basal release of taurine in cerebellar granule neurons, while the release is only moderately enhanced in hypoxia and ischemia in cerebral cortical astrocytes. The taurine release induced by ischemia is for the most part Ca2+-independent, a Ca2+-dependent mechanism being discernible only in hippocampal slices from developing mice. Moreover, a considerable portion of hippocampal taurine release in ischemia is mediated by the reversal of Na+-dependent transporters. The enhanced release in adults may comprise a swelling-induced component through Cl- channels, which is not discernible in developing mice. Excitotoxic concentrations of glutamate also potentiate taurine release in mouse hippocampal slices. The ability of ionotropic glutamate receptor agonists to evoke taurine release varies under different cell-damaging conditions, the N-methyl-D-aspartate-evoked release being clearly receptor-mediated in ischemia. Neurotoxic ammonia has been shown to provoke taurine release from different brain preparations, indicating that the ammonia-induced release may modify neuronal excitability in hyperammonic conditions. Taurine released simultane ously with an excess of excitatory amino acids in the hippocampus under ischemic and other neuron-damaging conditions may constitute an important protective mechanism against excitotoxicity, counteracting the harmful effects which lead to neuronal death. The release of taurine may prevent excitation from reaching neurotoxic levels.

Similar articles

• Enhanced release of adenosine under cell-damaging conditions in the developing and adult mouse hippocampus.

  Saransaari P, Oja SS. Saransaari P, et al. Neurochem Res. 2003 Sep;28(9):1409-17. doi: 10.1023/a:1024956701683. Neurochem Res. 2003. PMID: 12938864

• Taurine release in mouse brain stem slices under cell-damaging conditions.

  Saransaari P, Oja SS. Saransaari P, et al. Amino Acids. 2007;32(3):439-46. doi: 10.1007/s00726-006-0375-1. Epub 2006 Sep 27. Amino Acids. 2007. PMID: 16998716

• Modulation of taurine release by glutamate receptors and nitric oxide.

  Oja SS, Saransaari P. Oja SS, et al. Prog Neurobiol. 2000 Nov;62(4):407-25. doi: 10.1016/s0301-0082(00)00005-8. Prog Neurobiol. 2000. PMID: 10856611 Review.

• [Cerebral ischemia-hypoxia and biophysical mechanisms of neurodegeneration and neuroprotection effects].

  Mahura IS. Mahura IS. Fiziol Zh (1994). 2003;49(2):7-12. Fiziol Zh (1994). 2003. PMID: 12945108 Review. Ukrainian.

Cited by

• Deletion of TRAAK potassium channel affects brain metabolism and protects against ischemia.

  Laigle C, Confort-Gouny S, Le Fur Y, Cozzone PJ, Viola A. Laigle C, et al. PLoS One. 2012;7(12):e53266. doi: 10.1371/journal.pone.0053266. Epub 2012 Dec 28. PLoS One. 2012. PMID: 23285272 Free PMC article.

• Creatine, Glutamine plus Glutamate, and Macromolecules Are Decreased in the Central White Matter of Premature Neonates around Term.

  Koob M, Viola A, Le Fur Y, Viout P, Ratiney H, Confort-Gouny S, Cozzone PJ, Girard N. Koob M, et al. PLoS One. 2016 Aug 22;11(8):e0160990. doi: 10.1371/journal.pone.0160990. eCollection 2016. PLoS One. 2016. PMID: 27547969 Free PMC article.

• Neuropsychiatric morbidity in adolescent and adult succinic semialdehyde dehydrogenase deficiency patients.

  Knerr I, Gibson KM, Jakobs C, Pearl PL. Knerr I, et al. CNS Spectr. 2008 Jul;13(7):598-605. doi: 10.1017/s1092852900016874. CNS Spectr. 2008. PMID: 18622364 Free PMC article.

• Ex vivo (1)H nuclear magnetic resonance spectroscopy reveals systematic alterations in cerebral metabolites as the key pathogenetic mechanism of bilirubin encephalopathy.

  Hu W, Cheng X, Ye X, Zhao L, Huang Y, Zhu H, Yan Z, Wang X, Wang X, Bai G, Gao H. Hu W, et al. Mol Brain. 2014 Nov 26;7:87. doi: 10.1186/s13041-014-0087-5. Mol Brain. 2014. PMID: 25424547 Free PMC article.

• Effects of Taurine Supplementation on Neuronal Excitability and Glucose Homeostasis.

  El Idrissi A, El Hilali F, Rotondo S, Sidime F. El Idrissi A, et al. Adv Exp Med Biol. 2017;975 Pt 1:271-279. doi: 10.1007/978-94-024-1079-2_24. Adv Exp Med Biol. 2017. PMID: 28849462

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal